Search Results Search Sort by RelevanceMost Recent Case and Commentary Jan 2005 Mrs. Scott's Plan for the Future, Option Assessment Jennifer Reenan, MD Virtual Mentor. 2005;7(1):80-86. doi: 10.1001/virtualmentor.2005.7.1.ccas14a-0501. Case and Commentary Jan 2005 Mrs. Scott's Plan for the Future, Option Comparison Jennifer Reenan, MD Virtual Mentor. 2005;7(1):80-86. doi: 10.1001/virtualmentor.2005.7.1.ccas14b-0501. Case and Commentary Jan 2005 Mrs. Scott's Plan for the Future, Additional Information Jennifer Reenan, MD Virtual Mentor. 2005;7(1):80-86. doi: 10.1001/virtualmentor.2005.7.1.ccas14c-0501. Case and Commentary Jan 2005 Respecting Patients' End-of-Life Decisions, Option Assessment Karine Morin, LLM Virtual Mentor. 2005;7(1):87-95. doi: 10.1001/virtualmentor.2005.7.1.ccas15a-0501. Case and Commentary Jan 2005 Respecting Patients' End-of-Life Decisions Option Comparison Karine Morin, LLM Virtual Mentor. 2005;7(1):87-95. doi: 10.1001/virtualmentor.2005.7.1.ccas15b-0501. Case and Commentary Jan 2005 Respecting Patients' End-of-Life Decisions, Additional Information Karine Morin, LLM Virtual Mentor. 2005;7(1):87-95. doi: 10.1001/virtualmentor.2005.7.1.ccas15c-0501. Case and Commentary Feb 2010 Technical Skill and Informed Consent Robert M. Sade, MD Does a surgeon’s complication rate in a randomized controlled trial constitute a “significant new finding” that must be reported to patients during the consent process? Virtual Mentor. 2010;12(2):87-90. doi: 10.1001/virtualmentor.2010.12.2.ccas3-1002. Case and Commentary Mar 2009 Is There a Duty to Inform Patients of Phase I Trials? Commentary 1 Courtenay R. Bruce, JD and Anne Lederman Flamm, JD Physicians must ask themselves ethical questions before recommending participation in phase I trials to patients. Virtual Mentor. 2009;11(3):207-211. doi: 10.1001/virtualmentor.2009.11.3.ccas2-0903. Case and Commentary Mar 2009 Is There a Duty to Inform Patients of Phase I Trials? Commentary 2 Thomas W. LeBlanc, MD, MA and Philip M. Rosoff, MD, MA Physicians must ask themselves ethical questions before recommending participation in phase I trials to patients. Virtual Mentor. 2009;11(3):211-214. doi: 10.1001/virtualmentor.2009.11.3.ccas2-0903. Medicine and Society Nov 2019 How to Integrate Lived Experience Into Quality-of-Life Assessment in Patients Considering Facial Transplantation Laura L. Kimberly, MSW, MBE, Allyson R. Alfonso, Elie P. Ramly, MD, Rami S. Kantar, MD, Arthur L. Caplan, PhD, and Eduardo D. Rodriguez, MD, DDS Facial transplantation must establish approaches to assessing QoL in candidates and recipients that use meaningful outcomes. AMA J Ethics. 2019;21(11):E980-987. doi: 10.1001/amajethics.2019.980. Pagination First page « First Previous page ‹ Previous … Page 21 Page 22 Page 23 Page 24 Page 25 Current page 26 Page 27 Page 28 Page 29 Next page Next › Last page Last »
Case and Commentary Jan 2005 Mrs. Scott's Plan for the Future, Option Assessment Jennifer Reenan, MD Virtual Mentor. 2005;7(1):80-86. doi: 10.1001/virtualmentor.2005.7.1.ccas14a-0501.
Case and Commentary Jan 2005 Mrs. Scott's Plan for the Future, Option Comparison Jennifer Reenan, MD Virtual Mentor. 2005;7(1):80-86. doi: 10.1001/virtualmentor.2005.7.1.ccas14b-0501.
Case and Commentary Jan 2005 Mrs. Scott's Plan for the Future, Additional Information Jennifer Reenan, MD Virtual Mentor. 2005;7(1):80-86. doi: 10.1001/virtualmentor.2005.7.1.ccas14c-0501.
Case and Commentary Jan 2005 Respecting Patients' End-of-Life Decisions, Option Assessment Karine Morin, LLM Virtual Mentor. 2005;7(1):87-95. doi: 10.1001/virtualmentor.2005.7.1.ccas15a-0501.
Case and Commentary Jan 2005 Respecting Patients' End-of-Life Decisions Option Comparison Karine Morin, LLM Virtual Mentor. 2005;7(1):87-95. doi: 10.1001/virtualmentor.2005.7.1.ccas15b-0501.
Case and Commentary Jan 2005 Respecting Patients' End-of-Life Decisions, Additional Information Karine Morin, LLM Virtual Mentor. 2005;7(1):87-95. doi: 10.1001/virtualmentor.2005.7.1.ccas15c-0501.
Case and Commentary Feb 2010 Technical Skill and Informed Consent Robert M. Sade, MD Does a surgeon’s complication rate in a randomized controlled trial constitute a “significant new finding” that must be reported to patients during the consent process? Virtual Mentor. 2010;12(2):87-90. doi: 10.1001/virtualmentor.2010.12.2.ccas3-1002.
Case and Commentary Mar 2009 Is There a Duty to Inform Patients of Phase I Trials? Commentary 1 Courtenay R. Bruce, JD and Anne Lederman Flamm, JD Physicians must ask themselves ethical questions before recommending participation in phase I trials to patients. Virtual Mentor. 2009;11(3):207-211. doi: 10.1001/virtualmentor.2009.11.3.ccas2-0903.
Case and Commentary Mar 2009 Is There a Duty to Inform Patients of Phase I Trials? Commentary 2 Thomas W. LeBlanc, MD, MA and Philip M. Rosoff, MD, MA Physicians must ask themselves ethical questions before recommending participation in phase I trials to patients. Virtual Mentor. 2009;11(3):211-214. doi: 10.1001/virtualmentor.2009.11.3.ccas2-0903.
Medicine and Society Nov 2019 How to Integrate Lived Experience Into Quality-of-Life Assessment in Patients Considering Facial Transplantation Laura L. Kimberly, MSW, MBE, Allyson R. Alfonso, Elie P. Ramly, MD, Rami S. Kantar, MD, Arthur L. Caplan, PhD, and Eduardo D. Rodriguez, MD, DDS Facial transplantation must establish approaches to assessing QoL in candidates and recipients that use meaningful outcomes. AMA J Ethics. 2019;21(11):E980-987. doi: 10.1001/amajethics.2019.980.